Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate...

por Prawjaeng, Juthamas, Leelahavarong, Pattara, Budtarad, Nuttakarn, Pilasant, Songyot, Chanjam, Chonticha, Katchamart, Wanruchada, Narongroeknawin, Pongthorn, Kitumnuaypong, Tasanee
Publicado 2023

A Data-Driven Analysis of the Economic Cost of Non-Pharmaceutical Interventions: A Cross-Country Comparison of Kenya, Singapore, and Thailand

por Briones, Jamaica, Wang, Yi, Prawjaeng, Juthamas, Wee, Hwee Lin, Kairu, Angela, Orangi, Stacey, Barasa, Edwine, Teerawattananon, Yot
Publicado 2022

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic

por Wang, Yi, Luangasanatip, Nantasit, Pan–ngum, Wirichada, Isaranuwatchai, Wanrudee, Prawjaeng, Juthamas, Saralamba, Sompob, Painter, Christopher, Briones, Jamaica Roanne, Teerawattananon, Yot
Publicado 2022

Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines

por Painter, Chris, Isaranuwatchai, Wanrudee, Prawjaeng, Juthamas, Wee, Hwee Lin, Chua, Brandon Wen Bing, Huynh, Vinh Anh, Lou, Jing, Goh, Fang Ting, Luangasanatip, Nantasit, Pan-Ngum, Wirichada, Yi, Wang, Clapham, Hannah, Teerawattananon, Yot
Publicado 2021